RECURSION PHARMACEUTICALS, INC. financial data

Symbol
RXRX on Nasdaq
Location
Salt Lake City, UT
Fiscal year end
31 December
Latest financial report
10-Q - Q3 2025 - 05 Nov 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 401% % -18%
Debt-to-equity 39% % 3%
Return On Equity -73% % 5%
Return On Assets -52% % 5.8%
Operating Margin -1656% % -174%

Shares

Label TTM Value / Value Unit Change %
Common Stock, Shares, Outstanding 491,800,501 shares 72%
Entity Public Float $1,508,300,000 USD 62%
Common Stock, Value, Issued $5,000 USD 67%
Weighted Average Number of Shares Outstanding, Basic 446,988,046 shares 58%
Weighted Average Number of Shares Outstanding, Diluted 446,988,046 shares 58%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax $43,689,000 USD -33%
Research and Development Expense $477,665,000 USD 67%
General and Administrative Expense $220,117,000 USD 67%
Costs and Expenses $767,253,000 USD 67%
Operating Income (Loss) $723,564,000 USD -84%
Nonoperating Income (Expense) $7,874,000 USD -30%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest $715,690,000 USD -87%
Income Tax Expense (Benefit) $147,000 USD 97%
Net Income (Loss) Attributable to Parent $715,543,000 USD -89%
Earnings Per Share, Basic -1 USD/shares -17%
Earnings Per Share, Diluted -1 USD/shares -17%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $659,836,000 USD 54%
Other Assets, Current $29,223,000 USD -32%
Assets, Current $714,105,000 USD 51%
Deferred Income Tax Assets, Net $957,000 USD
Property, Plant and Equipment, Net $111,706,000 USD 32%
Operating Lease, Right-of-Use Asset $47,812,000 USD -0.15%
Intangible Assets, Net (Excluding Goodwill) $322,344,000 USD 845%
Goodwill $162,042,000 USD 211%
Other Assets, Noncurrent $14,661,000 USD 3972%
Assets $1,399,526,000 USD 93%
Accounts Payable, Current $13,935,000 USD 517%
Employee-related Liabilities, Current $24,056,000 USD 22%
Accrued Liabilities, Current $53,102,000 USD 31%
Contract with Customer, Liability, Current $47,364,000 USD -4.5%
Liabilities, Current $155,103,000 USD 42%
Long-term Debt and Lease Obligation $11,902,000 USD -42%
Contract with Customer, Liability, Noncurrent $111,204,000 USD 608%
Deferred Income Tax Liabilities, Net $23,312,000 USD 13776%
Operating Lease, Liability, Noncurrent $50,028,000 USD -6.8%
Other Liabilities, Noncurrent $1,029,000 USD -66%
Liabilities $352,578,000 USD 75%
Accumulated Other Comprehensive Income (Loss), Net of Tax $34,093,000 USD
Retained Earnings (Accumulated Deficit) $1,967,879,000 USD -57%
Stockholders' Equity Attributable to Parent $1,046,948,000 USD 100%
Liabilities and Equity $1,399,526,000 USD 93%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $131,957,000 USD -29%
Net Cash Provided by (Used in) Financing Activities $40,527,000 USD 192%
Net Cash Provided by (Used in) Investing Activities $7,270,000 USD -9.3%
Common Stock, Shares Authorized 2,000,000,000 shares 0%
Common Stock, Shares, Issued 491,800,501 shares 72%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $93,867,000 USD 1.5%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $667,145,000 USD 53%
Deferred Tax Assets, Valuation Allowance $466,147,000 USD 53%
Deferred Tax Assets, Gross $541,362,000 USD 69%
Operating Lease, Liability $81,045,000 USD 64%
Depreciation $18,300,000 USD 15%
Payments to Acquire Property, Plant, and Equipment $1,832,000 USD -72%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent $681,450,000 USD -80%
Lessee, Operating Lease, Liability, to be Paid $101,194,000 USD 53%
Property, Plant and Equipment, Gross $203,734,000 USD 55%
Operating Lease, Liability, Current $11,525,000 USD 40%
Lessee, Operating Lease, Liability, to be Paid, Year Two $20,450,000 USD 97%
Lessee, Operating Lease, Liability, to be Paid, Year One $19,389,000 USD 93%
Operating Lease, Weighted Average Discount Rate, Percent 0.08 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount $20,149,000 USD 21%
Lessee, Operating Lease, Liability, to be Paid, Year Three $20,810,000 USD 98%
Deferred Tax Assets, Operating Loss Carryforwards $274,421,000 USD 133%
Unrecognized Tax Benefits $6,749,000 USD 25%
Lessee, Operating Lease, Liability, to be Paid, Year Four $16,790,000 USD 56%
Operating Lease, Payments $5,265,000 USD 33%
Additional Paid in Capital $2,980,729,000 USD 68%
Amortization of Intangible Assets $44,800,000 USD 204%
Depreciation, Depletion and Amortization $19,331,000 USD 162%
Deferred Tax Assets, Net of Valuation Allowance $75,215,000 USD 383%
Share-based Payment Arrangement, Expense $116,725,000 USD 80%
Interest Expense $98,000 USD 63%